Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00300443 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension
A Phase 2 study, sponsored by Allergan.
- Completed
- Registry status
- Phase 2
- Development phase
- 561
- Enrollment target
NCT00300443 is a Phase 2 study that has completed, run by Allergan. The registered enrollment target is 561 participants.
The verdict
NCT00300443, a Phase 2 study, has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 561 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the safety and efficacy of bimatoprost in patients with glaucoma or ocular hypertension
Interventions
- DRUG bimatoprost
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 561 participants |
| Start Date | 2005-12 |
| Est. Completion | 2007-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00300443
The ClinicalTrials.gov registry entry for NCT00300443 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 561 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allergan, which has 314 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which bimatoprost is the first listed.
NCT00300443 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00300443 about?
NCT00300443 is a clinical study titled "Safety and Efficacy Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension". The purpose of this study is to assess the safety and efficacy of bimatoprost in patients with glaucoma or ocular hypertension
What is the current status of trial NCT00300443?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 561 participants. The study started on 2005-12. Estimated completion is 2007-06.
What interventions are being tested in trial NCT00300443?
The interventions under investigation include: bimatoprost (DRUG).
Who is sponsoring clinical trial NCT00300443?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.